科研製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/01/31 | 5,740 | 5,760 | 5,710 | 5,720 | -80 | -1.4% | 185,600 |
2017/01/30 | 5,810 | 5,820 | 5,730 | 5,800 | -10 | -0.2% | 166,700 |
2017/01/27 | 5,770 | 5,840 | 5,760 | 5,810 | ±0 | ±0% | 174,000 |
2017/01/26 | 5,830 | 5,850 | 5,750 | 5,810 | +40 | +0.7% | 195,400 |
2017/01/25 | 5,750 | 5,800 | 5,730 | 5,770 | -30 | -0.5% | 213,000 |
2017/01/24 | 5,840 | 5,860 | 5,780 | 5,800 | -60 | -1% | 196,200 |
2017/01/23 | 5,880 | 5,900 | 5,850 | 5,860 | -90 | -1.5% | 136,100 |
2017/01/20 | 5,950 | 6,000 | 5,930 | 5,950 | -30 | -0.5% | 123,700 |
2017/01/19 | 5,980 | 6,040 | 5,970 | 5,980 | +30 | +0.5% | 178,700 |
2017/01/18 | 5,970 | 6,000 | 5,900 | 5,950 | -110 | -1.8% | 255,700 |
2017/01/17 | 6,180 | 6,200 | 6,060 | 6,060 | -120 | -1.9% | 86,300 |
2017/01/16 | 6,220 | 6,250 | 6,160 | 6,180 | -70 | -1.1% | 77,300 |
2017/01/13 | 6,200 | 6,270 | 6,200 | 6,250 | +70 | +1.1% | 77,600 |
2017/01/12 | 6,240 | 6,300 | 6,160 | 6,180 | -140 | -2.2% | 132,200 |
2017/01/11 | 6,430 | 6,460 | 6,290 | 6,320 | -90 | -1.4% | 206,500 |
2017/01/10 | 6,480 | 6,580 | 6,390 | 6,410 | -100 | -1.5% | 271,400 |
2017/01/06 | 6,400 | 6,530 | 6,360 | 6,510 | +140 | +2.2% | 317,100 |
2017/01/05 | 6,320 | 6,380 | 6,300 | 6,370 | +50 | +0.8% | 134,200 |
2017/01/04 | 6,270 | 6,350 | 6,270 | 6,320 | +120 | +1.9% | 208,500 |
2016/12/30 | 6,180 | 6,220 | 6,150 | 6,200 | +120 | +2% | 135,600 |
2016/12/29 | 6,220 | 6,270 | 6,060 | 6,080 | -100 | -1.6% | 146,200 |
2016/12/28 | 6,200 | 6,200 | 6,150 | 6,180 | -20 | -0.3% | 80,300 |
2016/12/27 | 6,220 | 6,290 | 6,180 | 6,200 | +20 | +0.3% | 143,300 |
2016/12/26 | 6,190 | 6,230 | 6,140 | 6,180 | +80 | +1.3% | 146,400 |
2016/12/22 | 6,150 | 6,220 | 6,090 | 6,100 | -70 | -1.1% | 127,200 |
2016/12/21 | 6,250 | 6,260 | 6,170 | 6,170 | -110 | -1.8% | 131,900 |
2016/12/20 | 6,240 | 6,300 | 6,210 | 6,280 | +40 | +0.6% | 189,300 |
2016/12/19 | 6,130 | 6,260 | 6,130 | 6,240 | +180 | +3% | 213,600 |
2016/12/16 | 6,050 | 6,150 | 6,040 | 6,060 | +70 | +1.2% | 215,700 |
2016/12/15 | 5,990 | 6,050 | 5,970 | 5,990 | -20 | -0.3% | 258,400 |
2016/12/14 | 6,080 | 6,140 | 6,000 | 6,010 | -100 | -1.6% | 132,700 |
2016/12/13 | 5,930 | 6,120 | 5,920 | 6,110 | +220 | +3.7% | 245,400 |
2016/12/12 | 5,840 | 5,910 | 5,810 | 5,890 | +140 | +2.4% | 250,100 |
2016/12/09 | 5,690 | 5,770 | 5,660 | 5,750 | +30 | +0.5% | 322,300 |
2016/12/08 | 5,750 | 5,770 | 5,680 | 5,720 | -90 | -1.5% | 325,400 |
2016/12/07 | 5,900 | 5,920 | 5,790 | 5,810 | -120 | -2% | 286,500 |
2016/12/06 | 5,960 | 5,980 | 5,910 | 5,930 | +30 | +0.5% | 186,700 |
2016/12/05 | 5,900 | 5,940 | 5,850 | 5,900 | -40 | -0.7% | 247,300 |
2016/12/02 | 5,950 | 5,980 | 5,900 | 5,940 | -70 | -1.2% | 228,000 |
2016/12/01 | 6,130 | 6,130 | 5,990 | 6,010 | -70 | -1.2% | 216,500 |
2016/11/30 | 6,140 | 6,170 | 6,060 | 6,080 | -50 | -0.8% | 197,400 |
2016/11/29 | 6,050 | 6,140 | 6,050 | 6,130 | +140 | +2.3% | 270,700 |
2016/11/28 | 6,000 | 6,000 | 5,900 | 5,990 | -60 | -1% | 348,700 |
2016/11/25 | 5,980 | 6,060 | 5,980 | 6,050 | +70 | +1.2% | 264,900 |
2016/11/24 | 6,100 | 6,110 | 5,970 | 5,980 | -170 | -2.8% | 446,100 |
2016/11/22 | 6,130 | 6,170 | 6,090 | 6,150 | -110 | -1.8% | 266,900 |
2016/11/21 | 6,170 | 6,280 | 6,140 | 6,260 | +90 | +1.5% | 240,700 |
2016/11/18 | 6,180 | 6,180 | 6,090 | 6,170 | ±0 | ±0% | 196,800 |
2016/11/17 | 6,140 | 6,210 | 6,130 | 6,170 | -50 | -0.8% | 179,500 |
2016/11/16 | 6,200 | 6,250 | 6,160 | 6,220 | +30 | +0.5% | 163,100 |
2051~
2100
件表示中 / 3725件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
科研薬 | 384,400円 | -6.4% | -71.8% | 4.94% | 42.94倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
ジーエヌアイ | 376,500円 | +21.7% | +999.9% | 0.00% | 15.77倍 | 5.22倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
JT傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がTOB実施 |
東和薬品 | 295,300円 | +7.9% | -3.3% | 2.71% | 8.21倍 | 0.85倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ゼリア新薬 | 204,800円 | +3.1% | -6.5% | 2.34% | 9.50倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム